These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9074812)

  • 1. Remnant-like very-low-density lipoprotein isolated from hypertriglyceridemic patients by immunoaffinity chromatography suppressed 3-hydroxy-3-methylglutaryl coenzyme A activity of cultured human skin fibroblasts.
    Shige H; Ishikawa T; Ikewaki K; Nishiwaki M; Higashi K; Nakajima K; Nakamura H
    Clin Chim Acta; 1997 Feb; 258(2):145-58. PubMed ID: 9074812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.
    Campos E; Nakajima K; Tanaka A; Havel RJ
    J Lipid Res; 1992 Mar; 33(3):369-80. PubMed ID: 1569386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion.
    Van Zuiden PE; Erickson SK; Cooper AD
    J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model development to describe the heterogeneous kinetics of apolipoprotein B and triglyceride in hypertriglyceridemic subjects.
    Barrett PH; Baker N; Nestel PJ
    J Lipid Res; 1991 May; 32(5):743-62. PubMed ID: 2072038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular processing of apolipoprotein B-containing lipoproteins from young post-infarction patients and healthy controls.
    Tornvall P; Regnström J; Hamsten A
    Eur J Clin Invest; 1995 Sep; 25(9):699-707. PubMed ID: 7498246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal suppression of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by hypertriglyceridemic very low density lipoprotein subclasses.
    Gianturco SH; Packard CJ; Shepherd J; Smith LC; Catapano AL; Sybers HD; Gotto AM
    Lipids; 1980 Jun; 15(6):456-63. PubMed ID: 7401943
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.
    Broyles FE; Walden CE; Hunninghake DB; Hill-Williams D; Knopp RH
    Am J Cardiol; 1995 Jul; 76(2):129A-135A. PubMed ID: 7604788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts.
    Gianturco SH; Brown FB; Gotto AM; Bradley WA
    J Lipid Res; 1982 Sep; 23(7):984-93. PubMed ID: 6292317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.
    Blum CB; Deckelbaum RJ; Witte LD; Tall AR; Cornicelli J
    J Clin Invest; 1982 Dec; 70(6):1157-69. PubMed ID: 6294137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro.
    Björkegren J; Karpe F; Vitols S; Tornvall P; Hamsten A
    J Lipid Res; 1998 Feb; 39(2):423-36. PubMed ID: 9508002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypes of hypertriglyceridemia caused by excess very-low-density lipoprotein.
    Sniderman AD; Tremblay A; De Graaf J; Couture P
    J Clin Lipidol; 2012; 6(5):427-33. PubMed ID: 23009778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE is necessary and sufficient for the binding of large triglyceride-rich lipoproteins to the LDL receptor; apoB is unnecessary.
    Bradley WA; Gianturco SH
    J Lipid Res; 1986 Jan; 27(1):40-8. PubMed ID: 3958613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of an apoE-poor subfraction of very low density lipoprotein in hypertriglyceridemic men.
    Evans AJ; Huff MW; Wolfe BM
    J Lipid Res; 1989 Nov; 30(11):1691-701. PubMed ID: 2614271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in mouse peritoneal macrophages.
    Angelin B
    Biochem J; 1988 Oct; 255(2):529-34. PubMed ID: 3202831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high carbohydrate-fat free diet alters the proportion of heparin-bound VLDL in plasma and the expression of VLDL-apoB-100 epitopes.
    Keidar S; Goldberg AC; Cook K; Bateman J; Schonfeld G
    Metabolism; 1990 Mar; 39(3):281-8. PubMed ID: 2308518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lovastatin on the secretion of very low density lipoprotein lipids and apolipoprotein B in the hypertriglyceridemic Zucker obese rat.
    Kasim SE; Elovson J; Khilnani S; Almario RU; Jen KL
    Atherosclerosis; 1993 Dec; 104(1-2):147-52. PubMed ID: 8141838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.